Neurogene Correlations
| NGNE Stock | 20.60 1.51 6.83% |
The current 90-days correlation between Neurogene and Lineage Cell Therapeutics is 0.19 (i.e., Average diversification). The correlation of Neurogene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Neurogene Correlation With Market
Weak diversification
The correlation between Neurogene and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neurogene and DJI in the same portfolio, assuming nothing else is changed.
Neurogene | Build AI portfolio with Neurogene Stock |
Moving together with Neurogene Stock
Moving against Neurogene Stock
| 0.79 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.65 | DSGN | Design Therapeutics | PairCorr |
| 0.6 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.6 | 0P6S | Bayer AG NA | PairCorr |
| 0.53 | VCYT | Veracyte | PairCorr |
| 0.51 | VERA | Vera Therapeutics | PairCorr |
| 0.43 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.38 | DRTS | Alpha Tau Medical | PairCorr |
| 0.33 | DVAX | Dynavax Technologies Trending | PairCorr |
| 0.31 | DNLI | Denali Therapeutics | PairCorr |
| 0.61 | ENTA | Enanta Pharmaceuticals | PairCorr |
| 0.6 | VTVT | vTv Therapeutics | PairCorr |
| 0.58 | VRDN | Viridian Therapeutics | PairCorr |
| 0.43 | SRZNW | Surrozen Warrant | PairCorr |
| 0.41 | VNDA | Vanda Pharmaceuticals Trending | PairCorr |
| 0.38 | VXRT | Vaxart Inc | PairCorr |
| 0.37 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.34 | KTTAW | Pasithea Therapeutics | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Neurogene Stock performing well and Neurogene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neurogene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LCTX | 2.81 | (0.18) | 0.00 | (0.02) | 0.00 | 4.68 | 15.77 | |||
| OCGN | 3.14 | (0.15) | 0.00 | (0.02) | 0.00 | 5.69 | 19.88 | |||
| FULC | 4.74 | 0.65 | 0.11 | (1.90) | 4.72 | 11.56 | 53.70 | |||
| AUTL | 4.03 | 0.32 | 0.10 | 0.18 | 3.91 | 11.98 | 27.74 | |||
| ADCT | 3.67 | 0.06 | 0.02 | 0.11 | 4.72 | 8.71 | 24.27 | |||
| BNTC | 2.74 | 0.04 | 0.01 | 0.09 | 5.90 | 5.58 | 29.53 | |||
| SLDB | 3.77 | (0.16) | (0.01) | 0.00 | 5.13 | 9.16 | 29.50 | |||
| PRTC | 1.95 | (0.04) | (0.02) | 0.01 | 2.63 | 4.53 | 14.71 | |||
| QSI | 4.71 | (0.51) | 0.00 | (0.06) | 0.00 | 11.69 | 34.79 | |||
| ALMS | 3.53 | 1.43 | 0.43 | 1.55 | 2.33 | 6.99 | 41.17 |